| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 2 | 2 | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 2.29 | 4.88 | 2.56 | 0.71 |
| Receivables | 1.46 | 1.40 | 2.15 | 1.59 |
| Inventory | 2.88 | 2.80 | 3.03 | 1.96 |
| Other | — | — | — | — |
| 6.63 | 9.07 | 7.74 | 4.27 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 2.15 | 2.08 | 2.22 | 1.03 |
| ST’ Debt | 0.16 | 0.11 | 0.09 | 0.22 |
| Other | 0.61 | 0.15 | 0.09 | 0.12 |
| 3.88 | 3.00 | 4.13 | 3.31 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.39 | 3.07 | — | — |
—
|
| ’25 | 1.48 | 2.01 | 2.57 | 3.31 |
9.36
|
| ’24 | 2.98 | 1.98 | 1.84 | 1.46 |
8.26
|
| ’23 | 0.72 | 1.29 | 2.16 | 2.83 |
7.00
|
| ’22 | 0.10 | 0.80 | 0.73 | 2.83 |
4.46
|
| ’21 | 0.03 | 0.03 | 0.03 | 0.04 |
0.13
|
| ’20 | 0.03 | 0.02 | 0.09 | 0.00 |
0.14
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (2.07) | 0.03 | — | — |
—
|
| ’25 | (1.27) | (1.04) | (0.50) | (2.34) |
(5.14)
|
| ’24 | (1.42) | (0.66) | (0.45) | (0.57) |
(3.09)
|
| ’23 | (2.31) | (1.33) | (1.27) | (1.20) |
(6.11)
|
| ’22 | (2.58) | (1.49) | (1.79) | (1.43) |
(7.29)
|
| ’21 | (1.27) | (1.40) | (1.31) | (3.31) |
(7.30)
|
| ’20 | (1.44) | (1.19) | (1.17) | (1.89) |
(5.68)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (2.11) | 0.02 | — | — |
—
|
| ’25 | (1.27) | (1.05) | (0.50) | (2.34) |
(5.16)
|
| ’24 | (1.42) | (0.66) | (0.45) | (0.58) |
(3.10)
|
| ’23 | (2.31) | (1.33) | (1.27) | (1.20) |
(6.11)
|
| ’22 | (2.60) | (1.49) | (1.79) | (1.43) |
(7.32)
|
| ’21 | (1.27) | (1.41) | (1.31) | (3.32) |
(7.32)
|
| ’20 | (1.44) | (1.19) | (1.17) | (1.89) |
(5.69)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (2.48) | (2.92) | — | — |
—
|
| ’25 | (4.08) | (1.20) | (3.20) | (6.88) |
(14.96)
|
| ’24 | (15.04) | (10.24) | (10.00) | — |
(35.12)
|
| ’23 | (107.52) | (115.20) | (28.16) | (19.84) |
(160.00)
|
| ’22 | (144.00) | (112.00) | (128.00) | (1.61) |
(478.08)
|
| ’21 | (256.00) | (528.00) | (208.00) | (2.88) |
(1.14k)
|
| ’20 | (928.00) | (400.00) | (368.00) | (352.00) |
(1.78k)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 157.44 | 36.48 | 8.40 | 5.84 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 896.00 | 220.80 | 75.20 | 37.04 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 35 | 25 | 13 | 45 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.13 | 0.28 | 0.64 | 0.21 | — | — | — |
Revenue/Emp
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.46 | 7.00 | 8.26 | 9.36 | ‡‡‡‡‡ | — | — |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 14.22% | 39.04% | 40.24% | 32.04% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.35) | (6.71) | (3.99) | (5.85) | — | — | — |
EBT
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (187.17%) | (95.95%) | (48.38%) | (62.51%) | ‡‡‡ | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.31) | (6.38) | (3.99) | (5.85) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.33 | 1.14 | 1.09 | 0.50 | — | — | — |
Depreciation
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 256.26 | 175.34 | 72.56 | 23.88 | ‡‡‡‡‡ | — | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (478.08) | (160.00) | (35.12) | (14.96) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (418.97) | (153.03) | (27.17) | (13.11) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.55) | (0.18) | (0.06) | (0.04) | ‡‡‡ | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (420.52) | (153.21) | (27.23) | (13.15) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 260.69 | 118.67 | 60.71 | 13.15 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.02 | 0.04 | 0.11 | 0.39 | ‡‡‡‡‡ | — | — |
Shares
|
| — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.70 | 0.25 | 0.47 | 0.25 | ‡‡‡ | — | — |
PS Ratio
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.69 | 0.37 | 0.56 | 0.46 | ‡‡‡ | — | — |
PB Ratio
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.29 | (0.02) | (0.09) | 0.08 | ‡‡‡‡ | — | — |
EV/Sales
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.18) | 0.02 | 0.24 | (0.14) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.29) | (6.11) | (3.09) | (5.14) | ‡‡‡ | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.03) | (0.01) | (0.01) | (0.02) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.32) | (6.11) | (3.10) | (5.16) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.88 | 2.75 | 6.08 | 3.61 | — | — | — |
Working Cap'
|
| — | ‡‡‡‡‡ | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.53 | 0.41 | 0.25 | 0.93 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.83) | (1.88) | (4.63) | (1.63) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.54 | 4.74 | 6.91 | 5.16 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (74.58%) | (68.17%) | (41.94%) | (57.76%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (187.45%) | (147.52%) | (108.02%) | (101.77%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (107.97%) | (137.63%) | (68.62%) | (97.00%) | — | — | — |
ROE
|
My Size, Inc. (MYSZ), a microcap innovator in smartphone-based measurement tech, exemplifies the classic small-cap saga: explosive revenue growth from $63,000 in 2019 to $8.3 million in 2024, driven by lean operations yielding $635,000 per employee, yet undermined by over 9,000% share dilution that cratered revenue per share and the stock price from 2023 highs near $28 to recent lows around $1. This pattern echoes historical traps in growth-hungry tech firms, where capital raises fund promise but erode shareholder value, leaving the stock at a rock-bottom 0.47x P/S amid stabilizing 40% gross margins and narrowing losses from -$10.5 million to -$4 million.
Bright spots emerge on the balance sheet—a $4.6 million net cash position, plunging debt, and surging working capital—coupled with recent CEO insider buys totaling over 293,000 shares, a vote of confidence historically preceding small-cap rebounds. Trading at a deep discount to book value (0.56x) and well below unanimous analyst targets implying 425% upside, MYSZ signals oversold potential if execution holds, reminiscent of post-dilution recoveries in nimble tech plays.
Analysts project a 2025 revenue dip to $3.1 million before a 2026 rebound, with breakeven margins in sight and minimal capex suiting its software focus—yet dilution risks and negative ROE persist as red flags. For risk-tolerant investors, this high-reward gamble warrants a watchlist spot, but tread cautiously: historical parallels demand vigilance on revenue sustainability and funding discipline.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.